The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

Transplantation

Volumn 73, Issue 6, 2002, Pages 968-973

  Razonable, Raymund R ^a   Brown, Robert A ^a   Wilson, Jennie ^a   Groettum, Cynthia ^a   Kremers, Walter ^a   Espy, Mark ^a   Smith, Thomas F ^a   Paya, Carlos V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS DNA;

ARTICLE; BLOOD; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LEUKOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIRUS DETECTION; VIRUS LOAD;

EID: 0037181418     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200203270-00025     Document Type: Article

References (19)

1. Infections in solid-organ transplant recipients
2. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients
3. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients
4. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
5. Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients
6. The role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?
7. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients
8. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation
9. Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay
10. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients
11. Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: Correlation to viremia and HCMV infection
12. Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR
13. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients
14. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: Clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients
15. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma
16. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease
17. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections
18. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture
19. Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation